Aplan, Peter D.
National Cancer Institute (NCI),
United States
2025 Rank: 77135
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2130 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77135 | 80221 |
| Total Cites | 6710 | 7723 |
| H-index | 51 | 53 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 201 | 206 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1030 | 1154 |
| Number of Single+First+Last Authored Papers | 88 | 88 |
| Total Cites to Single+First+Last Authored Papers | 3579 | 4088 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5206 | 5625 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.37 |
| Self-Citation Percentage |
13.12%
|
|
Aplan, Peter D.
National Institutes of Health (NIH),
United States
2024 Rank: 74081
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2080 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74081 | 76302 |
| Total Cites | 6405 | 7386 |
| H-index | 49 | 53 |
| Hm-index | 18 | 18 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 193 | 198 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1006 | 1130 |
| Number of Single+First+Last Authored Papers | 86 | 86 |
| Total Cites to Single+First+Last Authored Papers | 3447 | 3943 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4940 | 5337 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.38 |
| Self-Citation Percentage |
13.28%
|
|
Aplan, Peter D.
National Institutes of Health (NIH),
United States
2023 Rank: 73180
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2091 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73180 | 74049 |
| Total Cites | 6100 | 7056 |
| H-index | 47 | 52 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 180 | 185 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 984 | 1109 |
| Number of Single+First+Last Authored Papers | 87 | 87 |
| Total Cites to Single+First+Last Authored Papers | 3329 | 3822 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4683 | 5062 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.39 |
| Self-Citation Percentage |
13.55%
|
|
Aplan, Peter D.
National Cancer Institute (NCI),
United States
2022 Rank: 70839
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2083 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70839 | 72099 |
| Total Cites | 5701 | 6621 |
| H-index | 46 | 50 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 168 | 173 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 947 | 1072 |
| Number of Single+First+Last Authored Papers | 84 | 84 |
| Total Cites to Single+First+Last Authored Papers | 3135 | 3617 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4351 | 4712 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.41 |
| Self-Citation Percentage |
13.90%
|
|
Aplan, Peter D.
National Cancer Institute (NCI),
United States
2021 Rank: 68288
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2011 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68288 | 70722 |
| Total Cites | 5453 | 6350 |
| H-index | 46 | 49 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 161 | 166 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 912 | 1036 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 3022 | 3490 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4162 | 4515 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.41 |
| Self-Citation Percentage |
14.13%
|
|
Aplan, Peter D.
National Cancer Institute,
United States
2020 Rank: 65618
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1934 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65618 | 67710 |
| Total Cites | 5042 | 5896 |
| H-index | 43 | 46 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 154 | 159 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 894 | 1017 |
| Number of Single+First+Last Authored Papers | 84 | 84 |
| Total Cites to Single+First+Last Authored Papers | 2882 | 3340 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3803 | 4133 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.43 |
| Self-Citation Percentage |
14.48%
|
|